Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04568460 · ClinicalTrials.gov registry record · Phase 2
Standing Tall (Yima Nkqo)
A Phase 2 study of HIV, sponsored by Brigham and Women's Hospital.
- Active
- Registry status
- Phase 2
- Development phase
- 100
- Enrollment target
- 3
- Study locations
NCT04568460 is a Phase 2 study of HIV that is active but no longer recruiting, run by Brigham and Women's Hospital. The registered enrollment target is 100 participants, below the 440-participant average among 303 other HIV trials with a reported enrollment target (77% lower). The trial reports 3 study locations across 3 states.
The verdict
NCT04568460, a Phase 2 study of HIV, is active but no longer recruiting, sponsored by Brigham and Women's Hospital.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 2
- Development phase
- 100 participants
- Enrollment target
- 3
- Study locations
Study Summary
The investigators propose the Standing Tall study, a prospective randomised study of strategy to optimize community-based ART initiation in South Africa. Investigators will work closely with community members to integrate community-based ART. One hundred participants will be enrolled and followed for a total of up to 6 months. Those in the intervention arm will be provided with the ST intervention which includes a behavioral component and access to ART. The intervention will be linked to a clinic through a "Nurse Initiated Management of ART."
Conditions Studied
Interventions
- OTHER Intervention Group Sessions
Study Locations (3)
Massachusetts
- Brigham and Women's Hospital - Boston
Eastern Cape
- Desmond Tutu Health Foundation - East London
Western Cape
- Desmond Tutu Health Foundation - Cape Town
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2020-11-25 |
| Est. Completion | 2024-03-31 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04568460
The ClinicalTrials.gov registry entry for NCT04568460 describes a study currently listed as active not recruiting, categorized as Phase 2. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 440-participant average among 303 other HIV trials with a reported enrollment target (77% lower). The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with HIV appearing as the primary indexed condition, and to 1 intervention - of which Intervention Group Sessions is the first listed.
NCT04568460 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Massachusetts, Eastern Cape, Western Cape.
Frequently Asked Questions
What is clinical trial NCT04568460 about?
NCT04568460 is a clinical study titled "Standing Tall (Yima Nkqo)". The investigators propose the Standing Tall study, a prospective randomised study of strategy to optimize community-based ART initiation in South Africa. Investigators will work closely with community members to integrate community-based ART. One hundred participants will be enrolled and followed fo...
What is the current status of trial NCT04568460?
This trial is currently active not recruiting. It is a Phase 2 study. The enrollment target is 100 participants. The study started on 2020-11-25. Estimated completion is 2024-03-31.
What conditions does trial NCT04568460 study?
This clinical trial studies the following conditions: HIV.
What interventions are being tested in trial NCT04568460?
The interventions under investigation include: Intervention Group Sessions (OTHER).
Who is sponsoring clinical trial NCT04568460?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04568460 being conducted?
This trial has 3 study locations across Massachusetts, Eastern Cape, Western Cape. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Evaluating Gardasil HPV Vaccine Humoral and Cellular Immune Responses in People With and Without HIV
RECRUITING · Phase 2
-
Improving Physical Ability and Cellular Senescence Elimination in HIV
RECRUITING · Phase 2
-
Evaluation Of Semaglutide in Adults With Cocaine Use Disorder With and Without HIV
RECRUITING · Phase 2
-
Off-Label Medications for Alcohol Use Disorder Among Patients With HIV: Pilot Study 3 Semaglutide
RECRUITING · Phase 2
-
Neuroactive Steroid to Treat Depressed Mood: A Trial for People With HIV
RECRUITING · Phase 2
-
A Study of VRC07-523LS, PGT121.414.LS, and PGDM1400LS Broadly Neutralizing Monoclonal Antibodies Given Intravenously in Adult Participants Without HIV
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.